Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia.
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: To document the effects of appropriate and inappropriate empirical antibiotic therapy on mortality in a cohort of patients with bacteraemia due to methicillin-resistant Staphylococcus aureus (MRSA) and to summarize effects with previous studies. METHODS: In the retrospective cohort study, episodes of clinically significant MRSA bacteraemia during a 15 year period were included. Polymicrobial episodes were excluded unless MRSA was isolated in more than one bottle and co-pathogens were given appropriate empirical antibiotic treatment. Appropriate empirical treatment was defined as matching in vitro susceptibility and started within 48 h of blood-culture taking, except for single aminoglycosides or rifampicin. We assessed univariate and multivariate associations between appropriate empirical therapy and 30 day all-cause mortality. Multivariable analysis was conducted using backward stepwise logistic regression. We reviewed all studies assessing the effects of appropriate empirical antibiotic treatment on mortality for MRSA infections and compiled adjusted odds ratios (ORs) using a random effects meta-analysis. RESULTS: Five hundred and ten episodes of MRSA bacteraemia were included. There were no cases of community-acquired infection. The 30 day mortality was 43.9% (224/510) and was stable throughout the study period. Mortality was significantly higher among patients receiving inappropriate (168/342, 49.1%) compared with those receiving appropriate (56/168, 33.3%) empirical antibiotic treatment, P = 0.001. In the adjusted analysis the OR was 2.15 [95% confidence interval (CI) 1.34-3.46]. Pooling of six studies using adequate methodology for the adjusted analysis resulted in an OR of 1.98 (95% CI 1.62-2.44). CONCLUSIONS: Appropriate empirical antibiotic treatment has a significant survival benefit in MRSA bacteraemia. Treatment guidelines should consider this benefit.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among patients with documented MRSA infections, delays of > 24–48 h until antibiotic administration are associated with increased mortality in some studies [143–147], but not in others [148–154].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [146]
Citations
Cites
Hidron, A. I., Edwards, J. R., Patel, J., Horan, T. C., Sievert, D. M., Pollock, D. A., Fridkin, S. K., & National Healthcare Safety Network Team and Participating National Healthcare Safety Network Facilities (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591861 · Cited by 3,724
Sakoulas, G., Moise-Broder, P. A., Schentag, J., Forrest, A., Moellering, R. C., & Eliopoulos, G. M. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.6.2398-2402.2004 · Cited by 836
Soriano, A., Marco, F., Martinez, J. A., Pisos, E., Almela, M., Dimova, V. P., Alamo, D., Ortega, M., Lopez, J., & Mensa, J. (2008) · Clinical Infectious Diseases · doi:10.1086/524667 · Cited by 767
(1995) · American Journal of Infection Control · doi:10.1016/0196-6553(95)90104-3 · Cited by 709
Chang, F.-Y., Peacock, J. E., Musher, D. M., Triplett, P., MacDonald, B. B., Mylotte, J. M., O’Donnell, A., Wagener, M. M., & Yu, V. L. (2003) · Medicine · doi:10.1097/01.md.0000091184.93122.09 · Cited by 530
Stryjewski, M. E., Szczech, L. A., Benjamin, D. K., Inrig, J. K., Kanafani, Z. A., Engemann, J. J., Chu, V. H., Joyce, M. J., Reller, L. B., Corey, G. R., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/510386 · Cited by 348
Kim, S.-H., Kim, K.-H., Kim, H.-B., Kim, N.-J., Kim, E.-C., Oh, M.-D., & Choe, K.-W. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00700-07 · Cited by 300
Pathogenic Significance of Methicillin Resistance for Patients with Staphylococcus aureus Bacteremia
Soriano, A., Martinez, J. A., Mensa, J., Marco, F., Almela, M., Moreno-Martinez, A., Sanchez, F., Munoz, I., Jimenez de Anta, M. T., & Soriano, E. (2000) · Clinical Infectious Diseases · doi:10.1086/313650 · Cited by 256
Paul, M., Andreassen, S., Tacconelli, E., Nielsen, A. D., Almanasreh, N., Frank, U., Cauda, R., & Leibovici, L. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl372 · Cited by 214
Self-citationLodise, T. P., & McKinnon, P. S. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2005.02.007 · Cited by 199
Research works printed but not linked: 1
- EARSS, 2009, European Antimicrobial Resistance Surveillance System
Cited by
Items 101–200 of 225
Hazelton, B. J., Thomas, L. C., Ünver, T., & Iredell, J. R. (2012) · Journal of Medical Microbiology · doi:10.1099/jmm.0.050385-0 · Cited by 19
“, 2012), including BSIs due to Gram-positive organisms such as Staphylococcus aureus (Khatib et al., 2006; Paul et al., 2010), Enterococcus species (Suppli et al.”
BackgroundClinical presentation, management and outcomes of Staph aureus bacteremia (SAB) in older adults
Yahav, D., Schlesinger, A., Shaked, H., Goldberg, E., Paul, M., Bishara, J., & Leibovici, L. (2016) · Aging Clinical and Experimental Research · doi:10.1007/s40520-016-0543-4 · Cited by 17
“Results from these databases have been previously described [11, 12].”
MethodSelf-citationKim, J., Joo, E., Ha, Y. E., Park, S. Y., Kang, C., Chung, D. R., Song, J., & Peck, K. R. (2013) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-1829-5 · Cited by 20
Eskesen, A. N., Belle, M. A., & Blomfeldt, A. (2018) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2018.1470666 · Cited by 18
Kim, H. J., Choi, Q., Kwon, G. C., & Koo, S. H. (2019) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23077 · Cited by 16
Castanheira, M., Jones, R. N., & Sader, H. S. (2013) · Journal of Chemotherapy · doi:10.1179/1973947813y.0000000135 · Cited by 14
Paggi, R., Cenci, E., Socio, G. V. D., Belati, A., Marini, D., Gili, A., Camilloni, B., & Mencacci, A. (2021) · Pathogens · doi:10.3390/pathogens10091132 · Cited by 14
Ben‐Zvi, H., Drozdinsky, G., Kushnir, S., Avni, T., Scheuerman, O., Bisahra, J., & Yahav, D. (2018) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2018.08.011 · Cited by 13
Steinhaus, N., Al-talib, M., Ive, P., Boyles, T., Bamford, C., Davies, M.-A., Mendelson, M., & Wasserman, S. (2018) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2018.06.004 · Cited by 12
Ys, K., Kim, J., Cheon, S., & Sohn, K. M. (2020) · Infection and Chemotherapy · doi:10.3947/ic.2020.52.1.82 · Cited by 12
“10 Administration of inappropriate antibiotics was identified as an independent predictor for 11 mortality in many studies, which also have conflicting data [25, 26].”
BackgroundEvolving rapid methicillin-resistant Staphylococcus aureus detection: Cover all the bases
Veeraraghavan, B., Bakthavatchalam, Y., & Nabarro, L. (2017) · Journal of Global Infectious Diseases · doi:10.4103/0974-777x.199997 · Cited by 14
Kawasuji, H., Sakamaki, I., Kawamura, T., Ueno, A., Miyajima, Y., Matsumoto, K., Kawago, K., Higashi, Y., & Yamamoto, Y. (2020) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2020.01.017 · Cited by 14
Reilly, J., Jacobs, M. A., Friedman, B. C., Cleveland, K. O., Lombardi, D. A., & Castañeda-Ruiz, B. (2020) · Drugs - Real World Outcomes · doi:10.1007/s40801-020-00191-x · Cited by 12
“Current clinical and microbiologic treatments for bacteremia are far from ideal in terms of the time to effective therapy, pathogen-susceptibility, and specificity [4, 12].”
BackgroundContemporary genomic approaches in the diagnosis and typing of Staphylococcus aureus
Williamson, D. A., Heffernan, H., & Nimmo, G. R. (2015) · Pathology · doi:10.1097/pat.0000000000000236 · Cited by 14
Na, S. H., Kim, C.-J., Kim, M., Park, J. S., Song, K., Choe, P. G., Park, W. B., Bang, J. H., Kim, E. S., Park, S., et al. (2015) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2015.12.007 · Cited by 13
“In spite of progress, a considerable proportion of SAB patients are treated with inappropriate empirical antibiotics due to the timebetween the onset of bacteremia and receipt of blood culture results (Khatib et al., 2006; Kim et al., 2004; Paul et al., 2010; RodriguezBano et al., 2009; Shorr et al., 2008).”
BackgroundWeber, Z., Ariano, R. E., Lagacé-Wiens, P. R. S., & Zelenitsky, S. A. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.09.007 · Cited by 12
Lestin-Bernstein, F., Harberg, R., Schumacher, I., Briedigkeit, L., Heese, O., & Biedermann, K. (2021) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-021-01021-7 · Cited by 13
“aureus infections— were analysed as an entity because they were assessed to be equally effective and replaced each other depending on side effects [30, 31, 38].”
BackgroundGreen, J. R., Howard, J. C., Shankar, A., Clinghan, R., Luff, T., Birch, M., Pithie, A. D., Werno, A., Metcalf, S. C. L., & Chambers, S. T. (2020) · Infection Prevention in Practice · doi:10.1016/j.infpip.2020.100096 · Cited by 10
Bono, K. R., Caceda, J. A., Zhai, M., Horng, H., Goldstein, C., Sifri, Z. C., Cennimo, D. J., & Glass, N. E. (2022) · Journal of Surgical Research · doi:10.1016/j.jss.2022.11.054 · Cited by 10
Analysis of the utilization and cost of antibiotics at an intensive care unit in Surabaya
Setiawan, E., Felix, H., & Setiadi, A. P. (2017) · Pharmaciana · doi:10.12928/pharmaciana.v7i2.6767 · Cited by 10
“Terapi empirik yang tepat juga memberikan efek jangka panjang yaitu dapat menurunkan semua penyebab kematian secara signifikan dan memperpendek lama tinggal di rumah sakit (Paul et al., 2010; Zilberberg et al., 2008).”
BackgroundHow deadly is meticillin-resistant Staphylococcus aureus?
Fätkenheuer, G., & Kaasch, A. J. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70904-1 · Cited by 11
Kawamura, S., Karasawa, Y., Toda, N., Nakai, Y., Shibata, C., Kurokawa, K., Arai, J., Funato, K., Kurosaki, S., Maeshima, S., et al. (2020) · Gut and Liver · doi:10.5009/gnl19248 · Cited by 10
“Other Enterococcus 2 (2) 9 (11) 0 6 (8) Citrobacter freundii 0 6 (8) 0 0 Aeromonas hydrophila 1 (1) 8 (10) 1 (1) 9 (11) Clostridium spp.”
InfluentialEmpiric Vancomycin Reduction in a Pediatric Intensive Care Unit
Lanata, M. M., Díaz, A., Hecht, S. M., Katragkou, A., Gallup, N., BUCKINGHAM, D. A., Tansmore, J. L., Sargel, C. L., Watson, J. R., & Karsies, T. J. (2021) · PEDIATRICS · doi:10.1542/peds.2020-009142 · Cited by 9
Bai, A. D., Burry, L. D., Showler, A., Steinberg, M., Ricciuto, D. R., Fernandes, T., Chiu, A., Raybardhan, S., TOMLINSON, G. A., Bell, C. M., et al. (2015) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2015/212184 · Cited by 9
Turner, R. B., Lalikian, K., Fry, M. M., Schwartz, J., Chan, D., & Won, R. (2017) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2017.07.003 · Cited by 9
“Specifically, delay in initiation of antibiotic therapy for treatment of Staphylococcus aureus BSI has been associated with higher mortality (10-12).”
Yahav, D., Shaked, H., Goldberg, E., Yassin, S., Eliakim‐Raz, N., Paul, M., Bishara, J., & Leibovici, L. (2016) · Infection · doi:10.1007/s15010-016-0919-6 · Cited by 8
Self-citationHentzien, M., Strady, C., Vernet-Garnier, V., Servettaz, A., de Champs, C., Delmer, A. J., Bani‐Sadr, F., & N’Guyen, Y. (2017) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2017.1323346 · Cited by 8
Mun, S. J., Kim, S., Huh, K., Cho, S. Y., Kang, C., Chung, D. R., & Peck, K. R. (2021) · Medicine · doi:10.1097/md.0000000000025679 · Cited by 8
“aureus excluding single aminoglycoside or rifampicin.([24]) Defervescence was defined as an afebrile state in which tympanic body temperature remained lower than 38.”
BackgroundLima, R. D. F., Costa, E. M. M. D. B., Filho, J. H. S. D. L., de Medeiros, A. C. D., Pereira, J. V., & Granville‐Garcia, A. F. (2015) · The Journal of Contemporary Dental Practice · doi:10.5005/jp-journals-10024-1770 · Cited by 8
Manickam, K., Walkty, A. J., Lagacé-Wiens, P. R. S., Adam, H. J., Swan, B., McAdam, B., Pieroni, P., Alfa, M. J., & Karlowsky, J. A. (2013) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2013/201516 · Cited by 7
“Indeed, inadequate empirical antimicrobial therapy for S aureus bacteremia has been associated with increased mortality and prolonged time to defervescence in some, although not all, clinical studies (8-14).”
BackgroundFayyaz, M., Mirza, I. A., Abbasi, S. A., Ikram, A., Hussain, A., & Khan, I. (2015) · Journal of Virology and Microbiology · doi:10.5171/2015.621269 · Cited by 7
“A study conducted by Paul et al. (2010) highlighted that mortality was significantly higher among patients receiving inappropriate empirical therapy.”
BackgroundWächter, H., Yörük, E., Becker, K., Görlich, D., & Kahl, B. C. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10071371 · Cited by 7
“The number of patients that received inadequate initial therapy and that of patients with unnecessary second-line treatment was alarmingly high in our tertiary care university hospital, especially when considering that inadequate initial treatment was significantly associated with decreased survival in our present stu…”
BackgroundSalas, D. E., Minejima, E., Wu, J., Chong, F., Wang, J., She, R. C., Nieberg, P., & Wong‐Beringer, A. (2017) · PubMed · Cited by 8
Ceftobripole: Experience in staphylococcal bacteremia.
Soriano, À., & Morata, L. (2019) · PubMed Central · Cited by 7
Principles of Anti-Infective Therapy
Bradley, J. S., Gerber, J. S., Hersh, A. L., & Long, S. S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-75608-2.00289-5 · Cited by 7
Arango-Gil, I. S., Sandoval-Parra, D. A., Montoya-Jaramillo, S., Gil, A. A., González-Tapias, I., Urrego-Ramírez, A. S., Cardona-Gómez, M., Vesga-Naranjo, J. J., Ascuntar, J., Caraballo, C., et al. (2025) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2025.108155 · Cited by 6
Han, J., Edelstein, P. H., Bilker, W. B., & Lautenbach, E. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.09.001 · Cited by 6
“, oneormoreagents thatareactive invitroagainst the isolate), as well as timing of receipt, has been shown to decreasemortality in MRSA bacteremia.(32) Notably, in our study, themajority of patientswithbacteremiadue toMRSAwithboth SCCmec II and SCCmec IV received appropriate antimicrobial therapy (98.”
Nader, N., Medina, R. I., Pescador, L. Á., Mantilla, B. M., Bravo, J. S., & Gómez, C. (2019) · Biomédica · doi:10.7705/biomedica.v39i2.4072 · Cited by 6
Parkes‐Smith, J., Bergh, H., & Harris, P. N. A. (2022) · Pathology · doi:10.1016/j.pathol.2022.07.006 · Cited by 6
Tuon, F. F., Rocha, J. L. L., Leite, T. M., & Dias, C. (2014) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2013.11.006 · Cited by 6
“This simulation must be validated considering the following facts: (1) most cases of “fever” and laboratory alterations (mainly leukocytosis with immature cells) are not infection; (2) the infection is not severe, and we can wait for culture results; (3) the need for and effectiveness of antibiotic therapy in terminal…”
BackgroundHeterogeneity in the treatment of bloodstream infections identified from antibiotic exposure mapping
Caffrey, A. R., Babcock, Z. R., Lopes, V., Timbrook, T. T., & LaPlante, K. L. (2019) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4761 · Cited by 6
“patients is challenging as bloodstream infections are associated with high mortality rates, and evidence suggests that immediate treatment with appropriate therapies can significantly improve survival.(1,3,4) However, further complicating these decisions are the lack of real‐world evidence regarding the most effective…”
BackgroundCaracterización clínica y microbiológica de la bacteriemia por Staphylococcus aureus
Hincapié, C., Caraballo, C., Tibaduiza-García, M. F., Garcés-Rodríguez, D. D. J., Echeverri‐Toro, L. M., Ascuntar, J., León-Álvarez, A. L., & Jaimes, F. A. (2018) · Acta Médica Colombiana · doi:10.36104/amc.2018.1074 · Cited by 9
Adjunctive β-lactams for Staphylococcus aureus bacteremia: a narrative review
Chastain, D. B., White, B. P., Henao‐Martínez, A. F., Tu, P. J., Bland, C. M., Foster, R. A., & Cluck, D. B. (2025) · Therapeutic Advances in Infectious Disease · doi:10.1177/20499361251343969 · Cited by 6
“8,9,12 Once susceptibility is confirmed or rapid diagnostic results indicate the presence of MRSA (e.g., positive identification of the mecA gene), current evidence supports the use of cefazolin or an antistaphylococcal β -lactam (nafcillin or oxacillin) for methicillin-susceptible S. aureus (MSSA)…”
Thrombocytopaenia during methicillin-sensitive Staphylococcus aureus bacteraemia
Forsblom, E., Tielinen, I., Ruotsalainen, E., & Järvinen, A. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2877-4 · Cited by 5
Wade-Cummings, M., Mailman, J. F., Degelman, M. L., Phillips, C., & Vanstone, J. R. (2021) · The Canadian Journal of Hospital Pharmacy · doi:10.4212/cjhp.v74i1.3039 · Cited by 5
Wang, X., Guo, Z., Zhang, X., Zhang, G., Li, Q., Tian, X., Chen, D., & Luo, Z. (2022) · European Journal of Pediatrics · doi:10.1007/s00431-022-04729-9 · Cited by 5
Hagiya, H., Hagioka, S., & Otsuka, F. (2013) · Internal Medicine · doi:10.2169/internalmedicine.52.0023 · Cited by 5
“A delay in the administration of appropriate therapy for the treatment of MRSA bacteremia episodes is reported to lead to a worsening of the patient outcome (57).”
BackgroundHan, J., Bilker, W. B., Edelstein, P. H., Mascitti, K. B., & Lautenbach, E. (2012) · Epidemiology and Infection · doi:10.1017/s0950268812000295 · Cited by 5
“aureus [39, 40], awareness of a high likelihood of”
BackgroundJogenfors, A., Stark, L., Svefors, J., Löfgren, S., Malmvall, B., & Matussek, A. (2013) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-2013-7 · Cited by 5
“aureus (MRSA) in Sweden is low [5]; however, knowledge of the local prevalence of MRSA is crucial in the choice of empirical treatment [6].”
BackgroundDelerue, T., Cordel, H., Delerue, T., Figoni, J., Dziri, S., Billard‐Pomares, T., Bouchaud, O., Carbonnelle, É., & Zahar, J. (2019) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-019-03556-5 · Cited by 5
Lee, C., Chien, C., & Liu, J.-W. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/457435 · Cited by 6
“When a Staphylococcus-like organism (SLO) is microscopically found in Gram staining of blood culture (BC) specimen, it seems reasonable to administrate a glycopeptide (GP) for empirical therapy.e paper investigates the risk factors for 14-day mortality in patients with methicillin-resistance…”
BackgroundClinical diagnostic accuracy of suspected sources of bacteremia and its effect on mortality
Ruiz‐Giardín, J. M., Jiménez, B. C., Martin, R. M. A., Ortiz, J. L. J., Arenas, M. H. C., SanMartin, J. V., Cabello, N., Barrios, A., Rejas, D., Salazar, M. F., et al. (2013) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2013.05.010 · Cited by 5
“, where appropriate empirical antibiotic treatment had a significant survival benefit in MRSA bacteremia [9].”
BackgroundHamid, M. E. (2011) · Journal of Microbiology and Antimicrobials · doi:10.5897/jma.9000056 · Cited by 8
Bitterman, R., Awwad, A., Darawsha, B., Dallashi, H., Dishon‐Benattar, Y., Pollack, D., & Paul, M. (2025) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaf009 · Cited by 4
Self-citationPérez, M. G. J., Martiren, S., Escarrá, F., Reijtman, V. R., Mastroianni, A., Baino, A. N. V., Cedillo, C., Garcia, M. E., Taicz, M., & Bologna, R. (2017) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2017.10.007 · Cited by 4
Reddy, P. K., Sutar, A. R., Sahu, S., Thampi, B., Keswani, N., & Mehta, K. D. (2021) · International Journal of Advances in Medicine · doi:10.18203/2349-3933.ijam20214882 · Cited by 4
“001).(40) Further, in patients with septic shock, 28-day mortality was significantly higher with IET (61.”
BackgroundQuality indicators on the use of antimicrobials in critically ill patients
Vera, P., Palomar, M., & Álvarez-Lerma, F. (2014) · Medicina Intensiva · doi:10.1016/j.medin.2014.04.009 · Cited by 4
Consensus statement for the management of pediatric severe sepsis
日本集中治療医学会小児集中治療委員会 (2014) · Journal of the Japanese Society of Intensive Care Medicine · doi:10.3918/jsicm.21.67 · Cited by 3
An Electronic Algorithm to Identify Vancomycin-Associated Acute Kidney Injury
Cherian, J. P., Jones, G. F., Bachina, P., Helsel, T., Virk, Z., Lee, J. H., Fiawoo, S., Salinas, A. B., Dzintars, K., O’Shaughnessy, E. M., et al. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad264 · Cited by 3
Clinical characteristics and prognosis of Staphylococcus aureus bacteremia
Fenoll, R. G., Espinosa-Pérez, M., Bayo, S. M., Millán, V. F., Jiménez, M. C. M., Álvarez, R. M. M., Ruíz, M. P. P., Usón, M. C. V., & Paesa, C. R. (2022) · Revista Española de Quimioterapia · doi:10.37201/req/035.2022 · Cited by 3
“4% de nuestros casos, supone un riesgo elevado de mala evolución [12], mientras que la biterapia antiestafilocócica, recogida por nosotros en el 31,5% de los casos y similar a la reportada en la literatura DISCUSIÓN”
Optimizing Delivery of Care for Patients with MRSA Infection: Focus on Transitions of Care
McKinnon, P. S., Boening, A. J., & Amin, A. (2011) · Hospital Practice · doi:10.3810/hp.2011.04.391 · Cited by 4
Liu, L., Yuan, M., Sun, S., Wang, J., Shi, Y., Yu, Y., & Su, X. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s378249 · Cited by 3
“In actual clinical practice, up to 46% of empirical antibiotic treatments were shown to be inappropriate and approximately 50% were either unnecessary or broad-spectrum antibiotics.(12,13) Therefore, prompt identification of causative agents is critical for appropriate treatment.”
BackgroundChallenges and Advances in the Diagnosis of Bloodstream Infection
Song, Y., Neff, M., & Gyarmati, P. (2022) · Future Microbiology · doi:10.2217/fmb-2021-0304 · Cited by 3
Zencir, M., Arı, A., Yılmaz, N., Avcı, M., Çalık, Ş., Coşkuner, S. A., Bal, F., & Ağuş, N. (2016) · ANKEM Dergisi · doi:10.5222/ankem.2016.018 · Cited by 2
Staphylococcus aureus bacteremia in a tertiary care hospital in India
Abdulsalam, M. S., Gopalakrishnan, R., Suresh Kumar, D., Thirunarayan, M., Venkatesh, S., & Ramakrishnan, B. (2018) · Indian Journal of Medical Specialities · doi:10.1016/j.injms.2018.03.004 · Cited by 2
Barberán, J., Varona, J. F., & Tejeda, M. I. (2014) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(14)70803-0 · Cited by 2
Traitement des infections par des bactéries à Gram positif résistantes
Lenoble, M. (2011) · Médecine et Maladies Infectieuses · doi:10.1016/s0399-077x(11)70037-3 · Cited by 2
“[1] Paul M, Kariv G, Goldberg E, Raskin M, Shaked H, Hazzan R, et al.”
BackgroundBader, M. S. (2015) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0000000000000283 · Cited by 2
“In the literature, appropriate empiric antibiotic againstMRSAwas associatedwith survival benefit.(20) This study has several limitations.”
BackgroundJAID/JSC 感染症治療ガイドライン2017 ―敗血症およびカテーテル関連血流感染症―
創一, 荒., 笠井正志, 河合伸, 宏, 坂., & 俊彦, 真. (2018) · Kansenshogaku zasshi · doi:10.11150/kansenshogakuzasshi.92.10 · Cited by 4
Healthcare Setting and Methicillin Resistant Staphylococcus aureus
Kubde, V., Dangre-Mudey, G., & Mudey, A. B. (2020) · International Journal of Current Research and Review · doi:10.31782/ijcrr.2020.123128 · Cited by 2
Tehrani, M. K., Yazdi, M. H., & Pourmand, M. R. (2023) · Iranian Journal of Microbiology · doi:10.18502/ijm.v15i4.13510 · Cited by 2
“Over the past few decades, the incidence of S. aureus infection has increased significantly, causing many medical problems due to its resistance to antibiotics (2, 3).”
BackgroundJakobsen, R. S. (2023) · VBN Forskningsportal (Aalborg Universitet) · doi:10.54337/aau614555530 · Cited by 2
Yang, N., Wang, H., Feng, X., Lin, Q., Chen, B., Mi, Y., Zheng, Y., Qiu, L., Zhang, F., Jiang, E., et al. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.02325-24 · Cited by 1
“The covariates were chosen based on previous studies showing an effect on the clinical outcome and could be acquired at the onset of SAB (9, 21, 22).”
Vela, S., Serrano, C. B., de Gracia-León, A. I., Belmonte-Domingo, A., Pinto-Pla, C., Ferrer-Ribera, A., de Castro-Oliver, A., Torres, I., Colomina, J., & Oltra-Sempere, M. R. (2025) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2025.06.005 · Cited by 1
Vela, S., Serrano, C. B., de Gracia-León, A. I., Belmonte-Domingo, A., Pinto-Pla, C., Ferrer-Ribera, A., de Castro-Oliver, A., Torres, I., Colomina, J., & Oltra-Sempere, M. R. (2025) · Enfermedades infecciosas y microbiologia clinica (English ed ) · doi:10.1016/j.eimce.2025.06.017 · Cited by 1
No, T.-H., & Mun, S. J. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-12040-9 · Cited by 1
Wang, Y., Xiao, Z., Xi, H., Zhu, Q., Liu, P., & Zhao, R. (2025) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2025.151686 · Cited by 1
Song, Y., Kjellander, C., Robinson, W. D., Öhrmalm, L., Giske, C. G., & Gyarmati, P. (2025) · MicrobiologyOpen · doi:10.1002/mbo3.70158 · Cited by 1
“It has been shown that 46% of the empirical antibiotic treatments were inappropriate and may have contributed to a 35% increase in overall mortality when treating BSI (Ammerlaan et al. 2013; Paul et al. 2010).”
Development and Implementation System of the Initial Dose Setting for Vancomycin in the Night Shift
Hayashi, H., Niwa, T., Takeichi, S., Imanishi, Y., Tonogai, Y., Okayasu, S., Kitaichi, K., Yasuda, K., Murakami, N., & Itho, Y. (2014) · Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) · doi:10.5649/jjphcs.40.85 · Cited by 1
Do death certificates accurately record deaths due to bloodstream infection?
Heather, C. S., Foo, H., & Gosbell, I. B. (2014) · The Medical Journal of Australia · doi:10.5694/mja14.00694 · Cited by 1
Pérez, M. G. J., Martiren, S., Escarrá, F., Reijtman, V. R., Mastroianni, A., Baino, A. N. V., Cedillo, C., Garcia, M. E., Taicz, M., & Bologna, R. (2018) · Enfermedades infecciosas y microbiologia clinica (English ed ) · doi:10.1016/j.eimce.2017.10.014 · Cited by 1
Drwiega, E. N., Nichols, K. R., Kaschak, M., Walter, A., Winn, V., Relich, R. F., & Knoderer, C. A. (2019) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0000000000000772 · Cited by 1
Principles of Anti-Infective Therapy
Bradley, J. S., & Long, S. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-40181-4.00289-9 · Cited by 1
Use of antibiograms and changes in bacterial resistance patterns in the Ross Tilley Burn Centre
D’Abbondanza, J. A., Ziolkowski, N. I., Rehou, S., & Shahrokhi, S. (2023) · Burns Open · doi:10.1016/j.burnso.2023.11.002 · Cited by 1
High Early Mortality in Patients With Staphylococcus aureus Bloodstream Infection: A Call for Action
Mylotte, J. M. (2025) · Patient Safety · doi:10.33940/001c.125200 · Cited by 1
An Economic Evaluation of Antimicrobial Stewardship Programs in Metropolitan Australian Hospitals
Coulter, S. (2018) · Queensland University of Technology · doi:10.5204/thesis.eprints.116505 · Cited by 1
KAN KÜLTÜRLERİN DÜŞÜK MALİYETLİ VE HIZLI ÖLÇÜLEBİLMESİ İÇİN YENİ BİR YAKLAŞIM
Düzenli, G., & Karabay, O. (2014) · Gazi Üniversitesi Mühendislik-Mimarlık Fakültesi Dergisi · doi:10.17341/gummfd.37710
Callejo-Torre, F. (2015) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/14330
Antibioticoterapia probabilista en reanimación
Chterev, V., Benbara, A., Augustin, P., & Montravers, P. (2009) · EMC - Anestesia-Reanimación · doi:10.1016/s1280-4703(09)70445-1
Antibioticoterapia probabilistica in rianimazione
Malaquin, S., Mahjoub, Y., Montravers, P., & Dupont, H. (2017) · EMC - Anestesia-Rianimazione · doi:10.1016/s1283-0771(17)85872-2
Staphylococcus aureus bacteraemia - Disease progression and prognosis
Forsblom, E. (2014) · Helda - University of Helsinki Institutional Repository
Méndez, I. A., Riaño, D. F. H., Pachón-Barinas, D. P., Africano, F. J., González, I., Rojas, N. A., Ia, M., & Dp, P.-B. (2013) · Dialnet (Universidad de la Rioja)
Actualización en Bacteriemia por Staphylococcus Aureus
Rivera, S. A. A., Barragán, D. A., & Jaimes, F. A. (2014) · Medicina U.P.B. · Cited by 5
Shime, N. (2013) · Journal of the Japanese Society of Intensive Care Medicine · doi:10.3918/jsicm.20.561
Münchberg, U. (2015) · Common Library Network (Der Gemeinsame Bibliotheksverbund)
Diagnóstico precoz de la sepsis y su implicación en el manejo clínico de los pacientes
Quesada, F., & Dolores, M. (2016) · TDX (Tesis Doctorals en Xarxa)
Exploration de méthodes alternatives pour la détection de bactéries dans le sang
Templier, V. (2016) · theses.fr (ABES) · doi:10.70675/b68e6cb7zbb2fz47d0za4bdz4d30c3d7c3d5 · Cited by 2
Zencir, M., Arı, A., Yılmaz, N., Avcı, M., Çalık, Ş., Coşkuner, S. A., Bal, F., & Ağuş, N. (2016) · ANKEM Dergisi
Metadata
- Authors
- Paul, M., Kariv, G., Goldberg, E., Raskin, M., Shaked, H., Hazzan, R., Samra, Z., Paghis, D., Bishara, J., & Leibovici, L.
- Affiliations
- Tel Aviv University (IL)
- Rabin Medical Center (IL)
- Corresponding author
- Paul, Mical
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-10-14
- Volume
- 65
- Issue
- 12
- Pages
- 2658-2665
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2112191002
- Cited by
- 224
- References
- 44
- Citations by year
- 2026: 2 · 2025: 11 · 2024: 1 · 2023: 12 · 2022: 13 · 2021: 20 · 2020: 11 · 2019: 12 · 2018: 18 · 2017: 21 · 2016: 18 · 2015: 20 · 2014: 19 · 2013: 22 · 2012: 14
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Antimicrobial Chemotherapy (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Keywords
- methicillin-resistant Staphylococcus aureus, MRSA bacteremia, empirical antibiotic therapy, 30-day mortality, antimicrobial susceptibility, community-acquired MRSA, treatment guidelines
- MeSH terms
- Aged, Aged, 80 and over, Anti-Bacterial Agents, Blood, Cross Infection, Culture Media, Female, Humans, Male, Medication Errors, Microbial Sensitivity Tests, Middle Aged, Risk Factors, Staphylococcal Infections, Cohort Studies, Multivariate Analysis, Odds Ratio, Bacteremia, Treatment Outcome, Methicillin-Resistant Staphylococcus aureus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.